Eisai aims for novel drug discovery for neurodegenerative disorders

German firm Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Japan based Eisai have announced that b...

March 17, 2021 | Wednesday | News
QBiotics joins TDM Growth Partners to accelerate drug development timelines

QBiotics Group Limited, a Brisbane (Australia) life sciences company developing novel anticancer and wound healing pharm...

March 16, 2021 | Tuesday | News
Boehringer Ingelheim to develop innovative Peptides to treat Obesity

Boehringer Ingelheim and Gubra on March, 1st 2021 announced a new research and licensing agreement focused on ...

March 1, 2021 | Monday | News
HitGen, UPPTHERA collaborate for drug discovery research

Chinese firm HitGen has announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc to ...

March 2, 2021 | Tuesday | News
Insilico Medicine discovers industry first preclinical drug candidate using AI

China based Insilico Medicine has demonstrated a breakthrough in Artificial Intelligence ("AI") and drug disco...

February 25, 2021 | Thursday | News
China's Suntrap discovers LeSoleil to fight COVID-19 and future epidemics

AI-assisted computing has greatly improved the efficiency of new drug research and development. China's Suntrap Life Tec...

February 15, 2021 | Monday | News
The Next-generation antimalarial treatment designed to tackle the drug-resistance challenge

Since the previous century, Tropical and subtropical regions have been grappling under the parasitic...

February 9, 2021 | Tuesday | News
Korea approves first anti-COVID-19 monoclonal antibody treatment

Celltrion Group has announced that the Ministry of Food and Drug Safety (MFDS) of South Korea has granted conditional ma...

February 8, 2021 | Monday | News
India's Biocon Biologics to offer Oncology Biosimilars in over 30 countries

Biocon Biologics Ltd., a fully integrated ‘pure-play’ biosimilars company and a subsidiary of Bioc...

February 5, 2021 | Friday | News
Hong Kong develops formula for treating Alzheimer's disease

Researchers from the School of Chinese Medicine (SCM) at Hong Kong Baptist University (HKBU) have developed a ...

February 5, 2021 | Friday | News
Genesis Medtech collaborates with Penumbra to expand Neurovascular market in China

Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialise...

January 20, 2021 | Wednesday | News
Mitsubishi Tanabe & Takeda to accelerate data-driven drug discovery

Japanese firm Mitsubishi Tanabe Pharma Corporation (MTPC) has announced that MTPC and Takeda Pharmaceutical Company...

January 19, 2021 | Tuesday | News
Sosei and PharmEnable enter technology collaboration for AI-driven drug discovery

Sosei Group Corporation (Sosei Heptares) in Japan and PharmEnable, a UK drug discovery company, have announced...

January 12, 2021 | Tuesday | News
Fujifilm injects $2B into large-scale cell culture manufacturing site in US

FUJIFILM Corporation is making an investment of more than 200 Billion yen ($2 Billion) to establish a new...

January 8, 2021 | Friday | News
Y-Biologics, 3D Medicines collaborate to develop novel cancer therapeutics for China

The South Korean biotech company Y-Biologics and the China-based biopharmaceutical company 3D Medicines have entere...

January 6, 2021 | Wednesday | News
Singapore launches spin-off to develop treatment for intractable diseases

The Experimental Drug Development Centre (EDDC), a national platform for drug discovery and development hosted by A*STAR...

December 24, 2020 | Thursday | News
Antengene submits NDAs for XPOVIO (Selinexor) in multiple APAC markets

Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and c...

December 4, 2020 | Friday | News
Eisai and Wren Therapeutics collaborate for potential treatment of synucleinopathies

Japanese firm Eisai Co., Ltd. and US based Wren Therapeutics Ltd. have announced that the companies have entered into an...

December 1, 2020 | Tuesday | News
Korea's OliPass advisory board to evaluate osteoarthritis pain killer drug development

OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced...

November 25, 2020 | Wednesday | News
Koru Lifescience identifies drug compounds beneficial for COVID-19 trials

New Zealand's Koru Lifescience, drug discovery, and advanced formulation research laboratory in Auckland, has ident...

November 24, 2020 | Tuesday | News
Insilico announces AI-powered drug discovery collaboration with Janssen

Hong Kong-based Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecu...

November 11, 2020 | Wednesday | News
Australia evaluates hyperimmune immunoglobulin treatment for COVID-19

Researchers from the Kirby Institute at UNSW Sydney, Australia together with colleagues in the United States and Europ...

November 9, 2020 | Monday | News
Cerecin's Tricaprilin receives ODD in the Treatment of infantile spasms

Cerecin, a biopharmaceutical company focused on discovering and developing brain therapeutics, announced today that the ...

October 30, 2020 | Friday | News
CStone inks deal worth $353.5M for new antibody drug conjugate

CStone Pharmaceuticals has announced a licensing agreement with LegoChem Biosciences, Inc., (LCB) for the development an...

October 29, 2020 | Thursday | News
ASLAN to develop next-gen DHODH inhibitor in autoimmune conditions

ASLAN Pharmaceuticals, clinical-stage immunology focused biopharmaceutical company developing innovative treatments to t...

October 16, 2020 | Friday | News